Development of resistance to kanamycin.
D001414:Bacitracin / Q000494:pharmacology; D002701:Chloramphenicol / Q000494:pharmacology; D003023:Cloxacillin / Q000494:pharmacology; D004754:Enterobacter / Q000187:drug effects*; D004917:Erythromycin / Q000494:pharmacology; D004926:Escherichia coli / Q000187:drug effects*; D007612:Kanamycin / Q000494:pharmacology*; D008712:Methicillin / Q000494:pharmacology; D009355:Neomycin / Q000494:pharmacology; D009675:Novobiocin / Q000494:pharmacology; D010403:Penicillin Resistance; D010406:Penicillins / Q000494:pharmacology; D011511:Proteus / Q000187:drug effects*; D011550:Pseudomonas aeruginosa / Q000187:drug effects*; D013210:Staphylococcus / Q000187:drug effects*; D013752:Tetracycline / Q000494:pharmacology; D014217:Troleandomycin / Q000494:pharmacology
D010406:Penicillins; D001414:Bacitracin; D009675:Novobiocin; D007612:Kanamycin; D004917:Erythromycin; D002701:Chloramphenicol; D014217:Troleandomycin; D013752:Tetracycline; D009355:Neomycin; D003023:Cloxacillin; D008712:Methicillin